Status | Study |
Recruiting |
Study Name: Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery Condition: Epithelioid Hemangioendothelioma Date: 2017-05-01 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Identification of Biomarkers for Patients With Vascular Anomalies Condition: Vascular Anomaly Generalized Lymphatic Anomaly Kaposiform Date: 2016-12-15 |
Recruiting |
Study Name: Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes Condition: Advanced and/or Metastatic Sarcoma Date: 2016-06-16 Interventions: Drug: Durvalumab Age group |
Not yet recruiting |
Study Name: Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. Condition: Congenital Hemangioma Hemangioendothelioma Date: 2015-12-03 Interventions: Drug: Lipiodol® Ultra Fluid with surgical glues Lipiodol® Ultra Fluid and surgical glue mixtur |
Recruiting |
Study Name: Lymphatic Anomalies Registry Condition: Lymphatic Malformation Generalized Lymphatic Anomaly (GLA) Date: 2015-03-17 |
Recruiting |
Study Name: A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors Condition: Kaposiform Hemangioendothelioma (KHE) Kasabach-Merritt Syndrome Date: 2014-04-08 Interventions: Drug: Vincristine Vincristine |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2012-02-06 Interventions: Drug: Gemcitabine Hydrochloride |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |
Active, not recruiting |
Study Name: Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies Condition: Kaposiform Hemangioendotheliomas Tufted Angioma Date: 2009-09-10 Interventions: Drug: sirolimus liquid dosing based on trough levels |